NCT02655029

Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

Prospective, Non-interventional Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination, in a Greek Population With Hypertension

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,285 (actual)
• Sponsor: Servier Hellas Pharmaceuticals Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The main objective of this study is to record, in routine clinical practice, patients' adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination, during 4 months treatment.

Detailed description

This is a non-interventional study aiming to record adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels will be recorded, as well as safety and tolerability of this fixed dose combination.

Conditions

• Adherence to Medication Regime
• Hypertensive Disease

Interventions

Type	Name	Description
DRUG	Perindopril/Indapamide/Amlodipine fixed dose combination	Dose selection is based on investigators management.

Timeline

• Start date: 2015-11-25
• Primary completion: 2016-12-01
• Completion: 2016-12-21
• First posted: 2016-01-13
• Last updated: 2017-03-24

Locations

1 site across 1 country: Greece